Precigen, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for PGEN, updated each market day.
PGEN AI Sentiment
AI sees no strong directional signal for Precigen, Inc. Common Stock stock over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Precigen, Inc. Common Stock
Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.
Sector
Exchange
Market Cap
$1,511,275,429
Cap Tier
Employees
47
Headquarters
GERMANTOWN, MD
Listed Since
Aug. 8, 2013
Website
PGEN Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
PGEN Volatility
Precigen, Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
